Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: mc who wrote (2342)	2/13/1998 2:36:00 PM
From: Tunica Albuginea	Respond to of 7041

Gary, I leave for a few days and when I get back I find the same thing: stock manipulation, and hype. Meanwhile everything there is to know about phentolamine can be accessed by walking though ANY US hospital and asking your friendly nurse at the desk if you can just look up the 1997 edition of AHFS ( Amer Hosp Formulary Services ) book, the " Golden Standards " book published by the Who's Who in the US Pharmacology Universities. 30+ years of research on phentolamine /Vasomax, for free, by the No1, 2, 3, 4, 5, 6 etc researchers in the US. Then figure out if this is something a prospective US ED patient is likely to put in his mouth. I believe that simple exercise will save investors countless hours of rhetoric in this thread by Clueless and company, all IMHO. TA